Acessibilidade / Reportar erro

7th Brazilian Guideline of Arterial Hypertension: Presentation


Declaration of potential conflict of interest of authors/collaborators of 7th Brazilian Guideline of Arterial Hypertension If the last three years the author/developer of the Guidelines:

Introduction

On behalf of the Brazilian Society of Cardiology, Brazilian Society of Hypertension and Brazilian Society of Nephrology, I present to you the 7th Brazilian Guideline of Arterial Hypertension, result of the joint work of an expert team of renowned professionals appointed by their respective medical societies.

The production of this new guideline was necessary to update the knowledge accumulated over the past years, considering the Brazilian reality and clinical practice. The guidance and recommendations contained in this document reflect the evidence of the effectiveness of the interventions. The present text does not deal specifically with cost-effectiveness analyses. The major objective of the medical societies and authors is to guide health professionals on the preventive measures and care for individuals with arterial hypertension, aiming at reducing the complications of arterial hypertension, considered the major risk factor for cardiovascular disease.

The following table was used as reference for the grades of recommendation and levels of evidence.

Grades of recommendation: Class I: Conditions to which there is conclusive evidence or at least general consensus concerning the safety and usefulness/efficacy of the intervention; Class II: Conditions to which there is conflicting evidence and/or disagreement of opinion concerning the safety and usefulness/efficacy of the intervention; Class IIa: Evidence/opinion in favor of the intervention. Most experts agree; Class IIb: Less well-established safety and usefulness/efficacy, without predominance of favorable opinions on the intervention; Class III: Conditions to which there is evidence and/or consensus that the intervention is not useful/effective, and, in some cases, even harmful. Levels of evidence: Level A: Data derived from multiple consistent randomized controlled clinical trials, and/or a robust meta-analysis of randomized clinical trials; Level B: Data derived from a less robust meta-analysis, one single randomized trial or non- randomized trials (observational); Level C: Data derived from consensual expert opinion. We hope the concepts expressed in this guideline can be widely spread to a better and more comprehensive care of individuals with arterial hypertension.

Marcus Vinícius Bolívar Malachias


Abbreviations of the Brazilian Guideline of AH

Marcus Vinícius Bolívar Malachias

Publication Dates

  • Publication in this collection
    Sept 2016
Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
E-mail: revista@cardiol.br